Literature DB >> 19013383

Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy.

Ch Daumerie1, Th Duprez, A Boschi.   

Abstract

BACKGROUND: Thyroid-Associated Orbitopathy (TAO) is an autoimmune disease characterized by orbital inflammation involving both adipose tissue and extra-ocular muscles (EOM). Whereas bilateral and possibly asymmetric orbital involvement is commonly found at radiological work-up, mono-orbital involvement is poorly documented, and ascribed to an initial and/or transient stage of subsequent bilateral TAO.
METHODS: From a cohort of two hundred TAO patients, we selected retrospectively fourteen patients with initial clinical unilateral TAO. Five of them were excluded because of clinical bilateralization.
RESULTS: The sex ratio was 0.8 (4M, 5F), and mean age 44.6 years (range: 18-63). All patients were euthyroid when the initial magnetic resonance imaging (MRI) was performed. One patient was treated with Levothyroxine, because of subclinical hypothyroidism. Eight patients (six smokers) suffered from Graves' disease, of 1-4 years duration, for which they were treated with antithyroid drugs. A thyroidectomy was performed in two patients. None of the patients ever received radioiodine. Six patients remained euthyroid after stopping of the antithyroid regimen, and two became hypothyroid. Seven patients had active, and two severe TAO. Four of nine patients exhibited bilateralization of TAO on initial MRI. Clinical status ultimately improved or normalized in all. In two patients, MRI performed after 9 years demonstrated partial shrinkage of previously enlarged EOMs, together with fatty involution of involved muscles.
CONCLUSIONS: Unilateral TAO is not different and just as severe as bilateral TAO. At initial work-up MRI shows signs of bi-laterality in 45% (4/9), with mild involvement of 1 or 2 extra-ocular muscles. The radiological status of affected muscles does not normalize, even in the very long term.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013383     DOI: 10.1016/j.ejim.2008.01.013

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  15 in total

1.  Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.

Authors:  Kai Hou; Tao Ai; Wei-Kun Hu; Ban Luo; Yi-Ping Wu; Rong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

2.  Clinical characteristics and the treatment modalities of Graves' orbitopathy in a tertiary referral center in Turkey: changes over two decades.

Authors:  Mine Ozturk; Onur Konuk; Bercin Tarlan; Mehmet Muhittin Yalcın; Yavuz Kemal Arıbas; Fusun Balos Toruner; Mehmet Unal; Goksun Ayvaz
Journal:  Int Ophthalmol       Date:  2022-08-28       Impact factor: 2.029

Review 3.  Role of Structural, Metabolic, and Functional MRI in Monitoring Visual System Impairment and Recovery.

Authors:  Jeffrey R Sims; Anna M Chen; Zhe Sun; Wenyu Deng; Nicole A Colwell; Max K Colbert; Jingyuan Zhu; Anoop Sainulabdeen; Muneeb A Faiq; Ji Won Bang; Kevin C Chan
Journal:  J Magn Reson Imaging       Date:  2020-10-02       Impact factor: 4.813

4.  Bilateral versus unilateral thyroid eye disease.

Authors:  Mohsen Bahmani Kashkouli; Reza Kaghazkanani; Iraj Heidari; Nooshin Ketabi; Sara Jam; Shahrzad Azarnia; Farzad Pakdel
Journal:  Indian J Ophthalmol       Date:  2011 Sep-Oct       Impact factor: 1.848

5.  Not All Orbitopathy Is Graves': Discussion of Cases and Review of Literature.

Authors:  Neeraja Boddu; Maliha Jumani; Vibhor Wadhwa; Gitanjali Bajaj; Fred Faas
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

6.  Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.

Authors:  P Perros; L Hegedüs; L Bartalena; C Marcocci; G J Kahaly; L Baldeschi; M Salvi; J H Lazarus; A Eckstein; S Pitz; K Boboridis; P Anagnostis; G Ayvaz; A Boschi; T H Brix; N Currò; O Konuk; M Marinò; A L Mitchell; B Stankovic; F B Törüner; G von Arx; M Zarković; W M Wiersinga
Journal:  Orphanet J Rare Dis       Date:  2017-04-20       Impact factor: 4.123

7.  Clinical profile of thyroid eye disease and factors predictive of disease severity.

Authors:  Alankrita Muralidhar; Sima Das; Sweety Tiple
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

8.  Graves' orbitopathy: Management of difficult cases.

Authors:  Wilmar M Wiersinga
Journal:  Indian J Endocrinol Metab       Date:  2012-12

9.  Unilateral proptosis in thyroid eye disease with subsequent contralateral involvement: retrospective follow-up study.

Authors:  Diego Strianese; Raffaele Piscopo; Andrea Elefante; Manuela Napoli; Chiara Comune; Immacolata Baronissi; Raffaele Liuzzi; Mariantonia Ferrara; Alessia D'alessandro; Pasquale Ruggiero; Pasquale Napolitano; Piergiacomo Grassi; Adriana Iuliano; Carmela Russo; Arturo Brunetti; Giulio Bonavolontà
Journal:  BMC Ophthalmol       Date:  2013-05-30       Impact factor: 2.209

10.  The relationship between sex and symmetry in thyroid eye disease.

Authors:  Shaheen C Kavoussi; Joseph N Giacometti; J Javier Servat; Flora Levin
Journal:  Clin Ophthalmol       Date:  2014-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.